Back to search
FDAFDA · Food and drugs·Recall number Z-1838-2026

Medline Kits: 1) HEART TRANSPLANT BIOPSY, Model Number: DYNJ37543A

Published April 29, 2026 · Recall initiated: February 25, 2026

Summary

FDA records medical device Class II recall Z-1838-2026, published April 29, 2026 and initiated February 25, 2026. Recalling firm: Medline Industries, LP; Status: Ongoing; Reported quantity: 39 units; Lot: 1) DYNJ37543A, UDI-DI: 10193489919561(each), 40193489919562(case), Lot Number: 24DDA193. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medline Industries, LP
Distributor
US Nationwide distribution.
Lot
1) DYNJ37543A, UDI-DI: 10193489919561(each), 40193489919562(case), Lot Number: 24DDA193
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Medline Kits: 1) HEART TRANSPLANT BIOPSY, Model Number: DYNJ37543A recalled?

Yes. FDA published recall Z-1838-2026 on April 29, 2026. Reported hazard: The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

What should I do if I have this product?

Voluntary: Firm initiated · Letter